UK’s Izana Bioscience tests rheumatoid arthritis drug in COVID-19 patients
LONDON (Reuters) – UK-based biopharma company Izana Bioscience said it was testing its antibody therapy namilumab for the treatment of patients with rapidly worsening COVID-19 at the Humanitas Research Hospitals in Bergamo...
Read More